Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:39 AM
Ignite Modification Date:
2025-12-25 @ 3:39 AM
NCT ID:
NCT02829502
Eligibility Criteria:
Inclusion Criteria:
* Patients ≥ 18 years with newly symptoms of stroke
* Able to receive exenatide/placebo within 21 days after onset of symptoms
* Radiological confirmed diagnoses of ischemic stroke
* NIHSS between 1-20 at the onset of symptoms
* modified rankin scale (mRS) ≤ 2 prior to onset of symptoms
* Has given written informed consent
Exclusion Criteria:
* Intracerebral haemorrhage
* Subdural / epidural hemorrhage
* Subarachnoid haemorrhage
* Previously major structural damage to the brain
* Diabetes type 1
* Diabetes type 2
* Known atrial fibrillation
* \> 50% stenosis of internal carotid
* Known allergy to GLP-1 receptor agonists
* Hepatic impairment (ALT\> 3 x upper normal limit)
* Renal impairment (eGFR \<30 ml / min)
* Inflammatory bowel disease
* Previous pancreatitis
* Heart failure (NYHA class 3-4)
* Pregnancy or lactation
* Patient unable to co-operate to the investigation procedures
* Visualization of the middle cerebral artery bilaterally by transcranial dopple not possible
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02829502
Study Brief:
Protocol Section:
NCT02829502